ALNY   $298.76  -4.49% Market Closed After Close 298.76 0.0

Alnylam Pharmaceuticals, Inc.

EMA (20): 2026-06-24 the price crossed up the moving average line and demonstrates a strong upside trend.

EMA (50): 2026-06-30 the price crossed up the moving average line and formed a short-term upside trend.

EMA (100): 2026-07-07 the price crossed up the moving average line and formed a short-term upside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

Trend Type flat and down
Power None
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 10.01%
EMA (20) date of signal June 24, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 7.46%
EMA (50) date of signal June 30, 2026, 3 a.m.
EMA (100) Signals bullish reversal
EMA (100) Yield 0.59%
EMA (100) date of signal July 7, 2026, 3 a.m.
RSI Signals bullish
RSI (14) Yield 10.21%
RSI (14) date of signal June 29, 2026, 3 a.m.
MACD Signals bullish
MACD Yield 0.0
MACD date of signal July 8, 2026, 3 a.m.
Stochastic Signals bullish recovery
Stochastic Yield 7.46%
Stochastic date of signal June 30, 2026, 3 a.m.
Updated July 9, 2026, 11 p.m.